Discriminatory capacity of the HT score for OS, PFS, NRM, and the CAR T-cell–related toxicities CRS and ICANS. (A) Kaplan-Meier estimates of OS by the HT score. (B) Kaplan-Meier estimates of PFS by the HT score. (C) Cumulative incidence of NRM by the HT score. (D) Relative distribution of CRS severity by HT score. (E) Relative distribution of ICANS severity by HT score. The black line describes the difference between HT^high and HT^low patients.